The QualityStocks Daily

"The QualityStocks Daily", our free summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

Newsletter Archives

QualityStocksSpotlight Company

Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP)

Disseminated on behalf of Helus Pharma Inc., may include paid advertisements. Investment Considerations HLP003 is in Phase 3 development with FDA Breakthrough Therapy Designation for adjunctive treatment of major depressive disorder. Twelve-month data following two 16 mg doses demonstrated sustained improvements in depression symptoms, including 100% responder and 71% remission rates in the analyzed cohort. … Continue reading “Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP)”

View Profile

Helus Pharma Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}}

Interested in a live, online demonstration?

Get a walkthrough of our products and services.
  • Recognize the difference of our innovative, all-encompassing approach
  • See how we will drive results for your company
  • Understand the power of our partnerships to extend your reach and recognition in the investment community and beyond

Schedule a LIVE Demo

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered